Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 71335-1993

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 71335-1993). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713351993)

Label for Venlafaxine Hydrochloride ER 75 mg extended release capsules, packaged by Bryant Ranch Prepack in Burbank, CA. The label notes comparison to Effexor XR 75 mg capsules by Aurobindo Pharma. It includes storage instructions to keep at 20°-25°C and a warning that the product may cause drowsiness. The package count is 90 capsules, with NDC 71335-1993-1 and a barcode present.*

FDA Label Image

Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv). (Venlafaxine Fig1)

A pharmacokinetic chart depicting the effect of various interacting drugs on venlafaxine pharmacokinetic parameters (Cmax, AUC, ODV) with fold changes and 90% confidence intervals. The chart includes recommendations for concomitant use such as avoiding ethanol and caution with cimetidine, ketoconazole, metoprolol, and monitoring blood pressure. It plots fold change relative to a reference value.*

FDA Label Image

Figure 2: Effect Of Venlafaxine On The Pharmacokinetics Interacting Drugs And Their Active Metabolites. (Venlafaxine Fig2)

A chart illustrating the pharmacokinetic (PK) fold change and 90% confidence interval for various analytes when interacted with several drugs, including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. The chart plots Cmax and AUC changes relative to a reference value with recommendations for dose adjustments or caution noted where applicable.*

FDA Label Image

Figure 3: Pharmacokinetics Of Venlafaxine And Its Metabolite O-desmethylvenlafaxine (odv) In Special Populations. (Venlafaxine Fig3)

A chart depicting pharmacokinetic (PK) changes in venlafaxine in special populations including hepatic and renal impairments, CYP2D6 polymorphisms, age, and gender. The graph shows fold changes and 90% confidence intervals for Cmax, AUC, and ODV, with dosing recommendations based on observed changes.*

FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical structure of venlafaxine hydrochloride showing its molecular arrangement including a cyclohexanol group, a methoxy-substituted benzene ring, and a dimethylaminoethyl side chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.